<DOC>
	<DOC>NCT01359735</DOC>
	<brief_summary>This study compares HP802-247 versus an antibiotic ointment for healing the wound after Mohs surgery.</brief_summary>
	<brief_title>Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Bacitracin</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<criteria>Provide informed consent. Age â‰¥ 18 years and of either sex. Type I, II, or III skin as assessed by the Fitzpatrick Scale. Willing to comply with protocol instructions, including allowing all study assessments. Scheduled to have head or neck nonmelanoma skin cancers removed by Mohs micrographic surgery with final wound size of 8 mm to 20 mm in diameter or with 8 mm to 20 mm long axis if not circular. Acceptable state of health and nutrition, in the opinion of the Investigator. History of anaphylaxis, serum sickness, or erythema multiforme reaction to aprotinin, bovine serum albumin or bovine serum proteins, penicillin, streptomycin, or amphotericin B. Therapy with bloodthinning agents including aspirin within 14 days of the Baseline Visit (these may be resumed postsurgery). Subjects with platelet or coagulation disorders. Therapy with another investigational agent within thirty (30) days of Screening, or during the study. Current systemic therapy with cytotoxic drugs. Current therapy with chronic (&gt; 10 days) oral corticosteroids. In the opinion of the Investigator the subject has a current life expectancy of less than 1 year.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Wound</keyword>
	<keyword>non-melanoma skin cancer</keyword>
	<keyword>Mohs micrographic surgery</keyword>
	<keyword>Head or neck</keyword>
</DOC>